Literatur
- 1
Bennedbaek F N, Perrild H, Hegedüs L.
Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey.
Clin Endocrinol.
2000;
50
357-363
- 2
Bennedbaek F N, Hegedüs L.
Management of the solitary thyroid nodules: results of a North American Survey.
J Clin Endocrinol Metab.
2000;
85
2493-2498
- 3
Belfiore A, La Rosa G L, La Porta G A. et al .
Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex,
age, and multinodularity.
Am J Med.
1992;
93
363-369
- 4
Belfiore A, La Rosa G, Padova G, Sava L, Ippolito O, Vigneri R.
The frequency of cold thyroid nodules and thyroid malignancies in patients from an
iodine-deficient area.
Cancer.
1987;
60
3096-3102
- 5
Brauer V FH, Paschke R.
Pathophysiologische Grundlagen der Prävention und medikamentösen Therapie von euthyreoten
Schilddrüsenknoten.
Dtsch Med Wochenschr.
2003;
128
2324-2328
- 6
Brauer V FH, Hentschel B, Paschke R.
Therapieziele; Resultate und Perspektiven der medikamentösen Therapie von euthyreoten
Schilddrüsenknoten.
Dtsch Med Wochenschr.
2003;
128
2381-2387
- 7
Bonnema S J, Bennedbaek F N, Wiersinga W M. et al .
Management of the nontoxic multinodular goitre: a European questionnaire study.
Clin Endocrinol.
2000;
53
5-12
- 8
Ceccarelli, Bencivelli W, Vitti P, Grasso L, Pinchera A.
Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years’
retrospective study.
Clin Endocrinol.
2005;
62
331-335
- 9
Dietlein M, Dressler J, Grunwald F, Joseph K, Leisner B, Moser E, Reiners C, Rendl J,
Schicha H, Schneider P, Schober O. Deutsche Gesellschaft fur Nuklearmedizin .
Guideline for in vivo- and in vitro procedures for thyroid diseases (version 2).
Nuklearmedizin.
2003;
42
109-115
- 10
Dietlein M, Dressler J, Eschner W, Leisner B, Reiners C, Schicha H. Deutsche Gesellschaft
für Nuklearmedizin, Deutsche Gesellschaft für Medizinische Physik .
Procedure Guideline for Thyroid Scintigraphy (Version 2).
Nuklearmedizin.
2003;
42
120-122
- 11
Dietlein M, Dressler J, Grünwald F, Leisner B, Moser E, Reiners C, Schicha H, Schneider P,
Schober O. Deutsche Gesellschaft für Nuklearmedizin .
Guideline for Radioiodine Therapy for Benign Thyroid Diseases (Version 3).
Nuklearmedizin.
2004;
43
217-220
- 12
Dietlein M, Moka D, Dederichs B, Hunsch E, Lauterbach K W, Schicha H.
Kosten-Effektivitäts-Analyse: Radioiod oder thyreostatische Medikation bei der Primärbehandlung
der Immunhyperthyreose.
Nuklearmedizin.
1999;
38
7-14
- 13
Ferrari C, Reschini E, Paracchi A.
Treatment of the autonomous thyroid nodule: a review.
Eur J Endocrinol.
1996;
135
383-390
- 14
Franklyn J A.
Commentary: Lack of consensus in Europe in the management of nontoxic multinodular
goitre.
Clin Endocrinol.
2000;
53
3-4
- 15
Gharib H.
Changing concepts in the diagnosis and management of thyroid nodules.
Endocrinol Metab Clin North Am.
1997;
26
777-800
- 16
Hampel R, Kulberg T, Klein K. et al .
Goiter incidence in Germany is greater than previously suspected.
Med Klin.
1995;
90
324-329
- 17
Hegedus L, Bonnema S J, Bennedbaek F N.
Management of simple nodular goiter: current status and future perspectives.
Endocr Rev.
2003;
24
102-132
- 18
Hermus A R, Huysmans D A.
Treatment of benign nodular thyroid disease.
N Engl J Med.
1998;
338
1438-1447
- 19
Holm L E, Ludell G, Israelsson A, Dahlqvist I.
Incidence of Hypothyroidism Occurring After Iodine-131 Therapy for Hyperthyroidism.
J Nuclear Med.
1982;
23
103-107
- 20 „Informationen zur genetischen Beratung und Einverständniserklärung”, „Leitlinien
zu genetische Beratung”;. http://www.bvmedgen.de/welcome.html)
- 21
Kahaly G J, Dietlein M.
Cost estimation of thyroid disorders in Germany.
Thyroid.
2002;
12
909-914
- 22
Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, Hufner M, Niederle B,
Brabant G.
Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: german
evidence-based consensus recommendation.
Exp Clin Endocrinol Diabetes.
2004;
112
52-58
- 23
Klein E, Kracht J, Krüskemper H -L, Reinwein D, Scriba P C.
Praxis der Schilddrüsendiagnostik.
Dtsch Med Wochenschr.
1973;
98
2362-2370
- 24
Knudsen N, Laurberg P, Perrild H, Bulow I, Ovesen L, Jorgensen T.
Risk factors for goiter and thyroid nodules.
Thyroid.
2002;
12
879-888
- 25
Krohn K, Führer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, Paschke R.
Etiolgy of euthyroid and toxic multinodular goiter.
Endocrine Reviews.
2005;
26
504-524
- 26
Leenhardt L, Hejblum G, Franc B, Fediaevsky L P, Delbot T, Guillouzic D, Ménégaux F,
Guillausseau C, Hoang C, Turpin G, Aurengo A.
Indications and Limits of Ultrasound-Guided Cytology in the Management of Nonpalpable
Thyriod Nodules.
J Clin Endocrinol Metabolism.
1999;
84
24-28
- 27
Mazzaferri E L.
Thyroid cancer in thyroid nodules: finding a needle in the haystack.
Am J Med.
1992;
93
359-362
- 28
Mazzaferri E L.
Management of a solitary thyroid nodule.
N Engl J Med.
1993;
328
553-559
- 29
Mazzaferri E L, Robbins R J, Spencer C A, Braverman L E, Pacini F, Wartofsky L, Haugen B R,
Sherman S I, Cooper D S, Braunstein G D, Lee S, Davies T F, Arafah B M, Ladenson P W,
Pinchera A.
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk
patients with papillary thyroid carcinoma.
J Clin Endocrinol Metab.
2003;
88
1433-1441
- 30
Merchant S H, Izquierdo R, Khurana K.
Is repeated fine-needel aspiration cytology useful in the management of patients with
benign nodular thyroid disease.
Thyroid.
2000;
10
489-492
- 31
Miccoli P, Berti P, Materazzi G, Minuto M, Barellini L.
Minimally invasive video-assisted thyroidectomy: five years of experience.
J Am Coll Surg.
2004;
199
243-248
- 32
Miehle K, Paschke R.
Therapy of hyperthyroidism.
Exp Clin Endocrinol Diabetes.
2003;
111
305-318
- 33
Moser E, Pickardt C R, Mann K, Engelhardt D, Kirsch C M, Knesewitsch P, Tatsch K,
Kreisig T, Kurz C, Saller B.
Ergebnisse der Radiojod-Behandlung von Patienten mit immunogener und nicht immunogener
Hyperthyreose bei Anwendung unterschiedlicher Herddosen.
Nuklearmedizin.
1988;
27
98-104
- 34
Oertel Y C.
A pathologist trying to help endocrinologists to interpret cytopathology reports from
thyroid aspirates.
J Clin Endocrinol Metab.
2002;
87
1459-1461
- 35
Ortiz R, Hupart K H, Defesi C R. et al .
Effect of early referral to an endocrinologist on efficiacy and cost of evaluation
and development of treatment plans in patients with thyroid nodules.
J Clin Endocrinol Metab.
1998;
83
3803-3807
- 36
Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccagna S, Nardi F, Panunzi C, Rinaldi R,
Toscano V, Pacella C M.
Risk of Malignancy in Nonpalpable Thyroid Nodules: Predictive Value of Ultrasound
and Color-Doppler Features.
J Clin Endocrinol Metab.
2002;
87
1941-1946
- 37
Reiners C, Schneider P.
Radioiodine therapy of thyroid autonomy.
Eur J Nucl Med.
2002;
43
471-478
- 38
Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R, Schumm-Dräger P -M.
Prevalence of thyroid disorders in the working population of Germany: Ultrasonography
screening in 96,278 unselected employees.
Thyroid.
2004;
14
926-932
- 39
Reiners C, Geling M, Luster M, Farahati J, Mäder U.
Epidemiologie des Schilddrüsenkarzinoms.
Onkologe.
2005;
11
11-19
- 40
Rojeski M T, Gharib H.
Nodular thyroid diesase. Evaluation and management.
N Engl J Med.
1985;
313
428-436
- 41
Ross D S.
Editorial: Nonpalpable Thyroid Nodules-Managing an Epidemic.
J Clin Endocrinol Metabolism.
2002;
87
1938-1940
- 42
Saller B, Esser I, Horn K. et al .
Diagnostik und Therapie von Schilddrüsenkrankheiten.
Internist.
1997;
38
177-185
- 43
Singer A, Cooper D S, Daniels G H. et al .
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid
cancer.
Arch Intern Med.
1996;
156
2165-2172
- 44
Surks M I, Ortiz E, Daniels G H, Sawin C T, Col N F, Cobin R H, Franklyn J A, Hershman J M,
Burman K D, Denke M A, Gorman Cooper R S, Weissman N J.
Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.
JAMA.
2004;
14
228-238
- 45
Thomusch O, Machens A, Matuschka C, Dralle H.
Cost analysis of surgical procedures for toxic nodular goiter.
Exp Clin Endocrinol Diab.
1998;
106
71-73
- 46
Vidal-Trecan G M, Stahl J E, Durand-Zaleski I.
Managing toxic thyroid adenoma: a cost-effectiveness analysis.
Eur J Endocrinol.
2002;
146
283-294
- 47
Volzke H, Ludemann J, Robinson D M, Spieker K W, Schwahn C, Kramer A, John U, Meng W.
The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area.
Thyroid.
2003;
13
803-810
- 48
Völzke H, Alte D, Kohlmann T, Lüdemann J, Nauck M, John U, Meng W.
Reference intervals of serum thyroid function tests in a previously iodine-deficient
area.
Thyroid.
2005;
15
279
- 49
Wesche M F, Tiel V, Buul M M, Lips P, Smits N J, Wiersinga W M.
A randomized trial comparing levothyroxine with radioactive iodine in the treatment
of sporadic nontoxic goiter.
J Clin Endocrinol Metab.
2001;
86
998-1005
- 50
Wiersinga W M.
Is repeated fine-needle aspiration cytology indicated in (benign) thyroid nodules?.
Eur J Endocrinol.
1995;
132
661-662
1 Erarbeitet auf der Basis der Vorträge und Diskussion während der Sektionstagung vom
20.-22.11.2003 in Leipzig
Prof. Dr. med. Ralf Paschke
Medizinische Klinik und Poliklinik III, Universität Leipzig
Philipp-Rosenthal-Straße 27
04103 Leipzig
Phone: +49/341/9713201
Fax: +49/341/9713209
